Skip to main content

Table 1 Baseline characteristics of patients

From: Selecting short length nucleic acids localized in exosomes improves plasma EGFR mutation detection in NSCLC patients

Characteristic

All patients (N = 47)a

Age (years)

73 (52–85)

Gender

 Female

19 (40.4%)

 Male

28 (59.6%)

Histologic type

 Adenocarcinoma

32 (68.1%)

 Squamous cell carcinoma

9 (19.1%)

 Other

6 (12.8%)

Tumor stage

 I

5 (10.6%)

 II

2 (4.3%)

 III

9 (19.1%)

 IV

31 (66.0%)

M categoryb

 M0

16 (34.0%)

 M1a

8 (17.0%)

 M1b

3 (6.4%)

 M1c, single organ

3 (6.4%)

 M1c, multi organs

17 (36.2%)

Chemotherapy

 TKI-naïve

43 (91.5%)

 TKI-treated

4 (8.5%)

  1. Other not otherwise specified, TKI tyrosine kinase inhibitor
  2. aResults are expressed as median (range) or number (%)
  3. bAccording to the 8th TMN edition, M1a indicates lung metastases or pleural/pericardial malignant effusion or nodules; M1b indicates a single metastatic lesion in a single distant organ; M1c indicates multiple lesions in a single organ or multiple lesions in multiple organs
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us